You must log in to view this page.

Cyclerion Therapeutics Inc. – Filings and Transcripts

NASDAQ: CYCN
Share price (8/10/26): $3.58
Market cap (8/10/26): $16.8 million

Warning: Large portions of this site require JavaScript enabled in order to function properly. Please make sure JavaScript is enabled in your browser.

Please let us know at support@bamsec.com if you have any questions or concerns.

Search in Documents

Key Exhibits

External Links

Financials Filter

ended 06/30/26 Q2

ended 03/31/26 Q1

ended 12/31/25 FY 2025 – amended

ended 12/31/25 FY 2025

ended 09/30/25 Q3

Prospectuses and Registrations Filter

Business combination disclosure

Business combination disclosure

Business combination disclosure

Prospectus supplement

Details of business combination or exchange offer – amended

Ownership Filter

J. Wood Capital Advisors LLC

Tyndall Capital Partners L P

News Filter

Cyclerion Therapeutics and Korsana Biosciences Announce Merger Agreement

Announces Progress Toward CYC-126 Phase 2 Proof-Of-Concept Study With FDA Feedback and Formation of Clinical Advisory Board

Announces Strategic Agreement With Medsteer and Progress Toward Initiating Phase 2 Proof-Of-Concept Study for CYC-126 in Treatment-Resistant Depression

Announces Transformational Relaunch as a Neuropsychiatric Company

Proxies Filter

Additional info about upcoming vote

Definitive proxy

Additional info about upcoming vote

Definitive proxy

Proxy related to merger

Other Filter

Notice of effectiveness

Notice of effectiveness

Correspondence with the SEC

Letter from the SEC

Notice of effectiveness